Abstract
The factor V Leiden and prothrombin G20210A are genetic risk factors involved in venous thrombosis. The real utility of polymorphisms tests is questionable, since it is expensive and do not reduce the recurrence of VTE. These tests should be limited purpose and improper management of patients with factor V Leiden is concerning, since most patients will never suffer venous thromboembolism,…